Semaglutide, also known as Ozempic or Wegovy, is set to transform treatments for cardiovascular disease, but a change in ...
A groundbreaking study has revealed that an anti-obesity jab containing semaglutide, a drug used to treat obesity, significantly reduces the risk of heart attacks and strokes, regardless of the amount ...
Injections of a weight loss drug could be a ‘game changer’ for cardiovascular patients by cutting the risk of heart attacks or strokes.